Pfizer scraps San Francisco biotech move
This article was originally published in Scrip
Executive Summary
Pfizer has dealt a blow to San Francisco's life science industry by abandoning plans to fill a biotech research centre with its staff. The news comes a year after Pfizer announced an academic partnership with the University of California San Francisco (UCSF).